New inhaler shows promise for COPD patients in early trial
NCT ID NCT07140328
First seen Apr 09, 2026 · Last updated May 17, 2026 · Updated 7 times
Summary
This study tests a new medicine called HSK39004, given as an inhaler, to see if it helps people with chronic obstructive pulmonary disease (COPD) breathe better. About 50 adults aged 40 to 80 with COPD will take either the study drug or a placebo for 4 weeks. The main goal is to measure changes in lung function over 12 hours after each dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE LUNG DISEASE (COLD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jiangsu Provincial People's Hospital
Nanchang, Jiangsu, China
Conditions
Explore the condition pages connected to this study.